Agendia Profile Banner
Agendia Profile
Agendia

@Agendia

Followers
1,530
Following
2,045
Media
613
Statuses
5,131

We believe in delivering precision oncology to patients and physicians, empowering them with clear answers—and peace of mind—about their cancer treatment path.

Irvine, CA
Joined December 2009
Don't wanna be here? Send us removal request.
@Agendia
Agendia
18 hours ago
Quicker, more comprehensive results lead to better planning. Order #MammaPrint and #BluePrint from your core biopsy to personalize your treatment every step of the way:
Tweet media one
0
0
1
@Agendia
Agendia
3 days ago
Our #MammaPrint and #BluePrint genomic tests add increased certainty to treatment decisions for early-stage #breastcancer patients – ultimately supporting improved outcomes. Read more about the accuracy of MammaPrint and BluePrint in the NBRST study:
Tweet media one
0
0
1
@Agendia
Agendia
8 days ago
Our #MammaPrint and #BluePrint genomic tests are designed to match each patient to the right treatment. Read more findings like the below from the NBRST trial: #breastcancer
Tweet media one
0
2
6
@Agendia
Agendia
10 days ago
During the NBRST trial, #MammaPrint & #BluePrint more accurately predicted patients’ responses to neo-adjuvant therapy – low-risk patients had a significantly lower response to neo-adjuvant chemotherapy (NAC) than high-risk patients. More on the findings:
Tweet media one
0
1
5
@Agendia
Agendia
13 days ago
Regardless of menopausal status, #MammaPrint and #BluePrint can provide more accurate predictions for patients with early-stage #breastcancer – leading to better planning. Learn more about findings from the NBRST study: #research
Tweet media one
0
1
8
@Agendia
Agendia
16 days ago
More informed treatment planning is here. View the NBRST study for data on how our #MammaPrint and #BluePrint genomic tests can make a difference for patients with early-stage breast cancer: #breastcancer #qualityoflife
Tweet media one
0
3
6
@Agendia
Agendia
21 days ago
By helping to minimize under- or over-treatment, #MammaPrint and #BluePrint can help doctors and their patients make more informed treatment decisions. Learn more about our genomic tests in the NBRST study: #breastcancer
Tweet media one
1
1
4
@Agendia
Agendia
23 days ago
Tweet media one
0
0
0
@Agendia
Agendia
24 days ago
More than 1,000 patients were enrolled in the NBRST study, which followed participants for 5 years. Click here to view findings from the trial, which demonstrate the accuracy of #MammaPrint and #BluePrint for #breastcancer treatment planning:
Tweet media one
0
1
5
@Agendia
Agendia
a month ago
Calling all #breastcancer care teams! What are your patients most worried about? Vote today and we will #DONATE $10 to @SusanGKomen . Click here to vote now:
Tweet media one
0
1
1
@Agendia
Agendia
a month ago
Happy Independence Day from all of us at Agendia!
Tweet media one
0
0
2
@Agendia
Agendia
a month ago
We had a great time at the #PMWC22 conference! Thank you to everyone who stopped by our booth! Click here to learn more about the latest data supporting the utility of #MammaPrint and #BluePrint for early-stage #breastcancer patients:
Tweet media one
0
1
3
@Agendia
Agendia
a month ago
Calling all #BreastCancer care teams! CAST your vote today and we will #DONATE $10 to @SusanGKomen . With the overwhelming support we received during #ASCO22 , @Agendia would like to open our poll to the public digitally! Click here to vote now:
Tweet media one
0
3
3